191 related articles for article (PubMed ID: 15687335)
21. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
[TBL] [Abstract][Full Text] [Related]
22. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
23. Role of the Src homology 2 (SH2) domain and C-terminus tyrosine phosphorylation sites of SH2-containing inositol phosphatase (SHIP) in the regulation of insulin-induced mitogenesis.
Wada T; Sasaoka T; Ishiki M; Hori H; Haruta T; Ishihara H; Kobayashi M
Endocrinology; 1999 Oct; 140(10):4585-94. PubMed ID: 10499514
[TBL] [Abstract][Full Text] [Related]
24. Reversal of denervation-induced insulin resistance by SHIP2 protein synthesis blockade.
Bertelli DF; Ueno M; Amaral ME; Toyama MH; Carneiro EM; Marangoni S; Carvalho CR; Saad MJ; Velloso LA; Boschero AC
Am J Physiol Endocrinol Metab; 2003 Apr; 284(4):E679-87. PubMed ID: 12453826
[TBL] [Abstract][Full Text] [Related]
25. Association of SH-2 containing inositol 5'-phosphatase 2 gene polymorphisms and hyperglycemia.
Ishida S; Funakoshi A; Miyasaka K; Shimokata H; Ando F; Takiguchi S
Pancreas; 2006 Jul; 33(1):63-7. PubMed ID: 16804414
[TBL] [Abstract][Full Text] [Related]
26. Impact of transgenic overexpression of SH2-containing inositol 5'-phosphatase 2 on glucose metabolism and insulin signaling in mice.
Kagawa S; Soeda Y; Ishihara H; Oya T; Sasahara M; Yaguchi S; Oshita R; Wada T; Tsuneki H; Sasaoka T
Endocrinology; 2008 Feb; 149(2):642-50. PubMed ID: 18039790
[TBL] [Abstract][Full Text] [Related]
27. Single nucleotide polymorphisms on SHIP2 is associated with Type 2 diabetes mellitus in Chinese Han population.
Hao YM; Liu QJ; Wang RY; Cao YP; Zhang Y; Zuo LF
Eur Rev Med Pharmacol Sci; 2015 Jan; 19(1):129-37. PubMed ID: 25635986
[TBL] [Abstract][Full Text] [Related]
28. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes.
Sharma PM; Son HS; Ugi S; Ricketts W; Olefsky JM
Mol Endocrinol; 2005 Feb; 19(2):421-30. PubMed ID: 15486046
[TBL] [Abstract][Full Text] [Related]
29. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
[TBL] [Abstract][Full Text] [Related]
30. Normalization of prandial blood glucose and improvement of glucose tolerance by liver-specific inhibition of SH2 domain containing inositol phosphatase 2 (SHIP2) in diabetic KKAy mice: SHIP2 inhibition causes insulin-mimetic effects on glycogen metabolism, gluconeogenesis, and glycolysis.
Grempler R; Zibrova D; Schoelch C; van Marle A; Rippmann JF; Redemann N
Diabetes; 2007 Sep; 56(9):2235-41. PubMed ID: 17596404
[TBL] [Abstract][Full Text] [Related]
31. Specific tyrosine phosphorylations mediate signal-dependent stimulation of SHIP2 inositol phosphatase activity, while the SH2 domain confers an inhibitory effect to maintain the basal activity.
Prasad NK; Werner ME; Decker SJ
Biochemistry; 2009 Jul; 48(27):6285-7. PubMed ID: 19518129
[TBL] [Abstract][Full Text] [Related]
32. Antisense oligonucleotides against the lipid phosphatase SHIP2 improve muscle insulin sensitivity in a dietary rat model of the metabolic syndrome.
Buettner R; Ottinger I; Gerhardt-Salbert C; Wrede CE; Schölmerich J; Bollheimer LC
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1871-8. PubMed ID: 17327370
[TBL] [Abstract][Full Text] [Related]
33. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice.
Fukui K; Wada T; Kagawa S; Nagira K; Ikubo M; Ishihara H; Kobayashi M; Sasaoka T
Diabetes; 2005 Jul; 54(7):1958-67. PubMed ID: 15983195
[TBL] [Abstract][Full Text] [Related]
34. Developmental defects and rescue from glucose intolerance of a catalytically-inactive novel Ship2 mutant mouse.
Dubois E; Jacoby M; Blockmans M; Pernot E; Schiffmann SN; Foukas LC; Henquin JC; Vanhaesebroeck B; Erneux C; Schurmans S
Cell Signal; 2012 Nov; 24(11):1971-80. PubMed ID: 22750293
[TBL] [Abstract][Full Text] [Related]
35. SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cells.
Gorgani-Firuzjaee S; Meshkani R
Free Radic Biol Med; 2015 Dec; 89():679-89. PubMed ID: 26456051
[TBL] [Abstract][Full Text] [Related]
36. SIP/SHIP inhibits Xenopus oocyte maturation induced by insulin and phosphatidylinositol 3-kinase.
Deuter-Reinhard M; Apell G; Pot D; Klippel A; Williams LT; Kavanaugh WM
Mol Cell Biol; 1997 May; 17(5):2559-65. PubMed ID: 9111325
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of SH2-domain containing inositol phosphatase 2 (SHIP2) in insulin producing INS1E cells improves insulin signal transduction and induces proliferation.
Grempler R; Leicht S; Kischel I; Eickelmann P; Redemann N
FEBS Lett; 2007 Dec; 581(30):5885-90. PubMed ID: 18061583
[TBL] [Abstract][Full Text] [Related]
38. Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2.
Suwa A; Yamamoto T; Sawada A; Minoura K; Hosogai N; Tahara A; Kurama T; Shimokawa T; Aramori I
Br J Pharmacol; 2009 Oct; 158(3):879-87. PubMed ID: 19694723
[TBL] [Abstract][Full Text] [Related]
39. Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population.
Ishihara H; Sasaoka T; Kagawa S; Murakami S; Fukui K; Kawagishi Y; Yamazaki K; Sato A; Iwata M; Urakaze M; Ishiki M; Wada T; Yaguchi S; Tsuneki H; Kimura I; Kobayashi M
FEBS Lett; 2003 Nov; 554(3):450-4. PubMed ID: 14623110
[TBL] [Abstract][Full Text] [Related]
40. SH2-containing inositol 5'-phosphatase 2 selectively impairs hypothalamic insulin signalling and regulation of food intake in mice.
Ichihara Y; Wada T; Soeda Y; Ishii Y; Sasahara M; Tsuneki H; Sasaoka T
J Neuroendocrinol; 2013 Apr; 25(4):372-82. PubMed ID: 23286299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
